Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00740181 · ClinicalTrials.gov registry record · Phase 2
Decitabine, Cytarabine, GCSF for Refractory AML/MDS
A Phase 2 study, sponsored by Brown University.
- Terminated
- Registry status
- Phase 2
- Development phase
- 9
- Enrollment target
NCT00740181 is a Phase 2 study that was terminated before completion, run by Brown University. The registered enrollment target is 9 participants.
The verdict
NCT00740181, a Phase 2 study, was terminated before completion, sponsored by Brown University.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 9 participants
- Enrollment target
Study Summary
This study will determine the activity of decitabine, low dose cytarabine (ARA-C) and G-CSF for patients with myelodysplasia and leukemia.
Interventions
- DRUG chemotherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2008-08 |
| Est. Completion | 2010-04 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00740181
The ClinicalTrials.gov registry entry for NCT00740181 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brown University, which has 231 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which chemotherapy is the first listed.
NCT00740181 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00740181 about?
NCT00740181 is a clinical study titled "Decitabine, Cytarabine, GCSF for Refractory AML/MDS". This study will determine the activity of decitabine, low dose cytarabine (ARA-C) and G-CSF for patients with myelodysplasia and leukemia.
What is the current status of trial NCT00740181?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 9 participants. The study started on 2008-08. Estimated completion is 2010-04.
What interventions are being tested in trial NCT00740181?
The interventions under investigation include: chemotherapy (DRUG).
Who is sponsoring clinical trial NCT00740181?
This trial is sponsored by Brown University, which has 231 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.